H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report)’s share price crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $22.00 and traded as high as $24.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares.
H. Lundbeck A/S Stock Down 0.0 %
The company has a debt-to-equity ratio of 0.32, a current ratio of 1.15 and a quick ratio of 0.71. The firm has a 50-day simple moving average of $22.00 and a two-hundred day simple moving average of $22.00. The company has a market cap of $21.91 billion, a PE ratio of 25.00 and a beta of 0.68.
H. Lundbeck A/S Company Profile
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
Read More
- Five stocks we like better than H. Lundbeck A/S
- The 3 Best Fintech Stocks to Buy Now
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
